1190880-92-2Relevant articles and documents
SULFONAMIDE COMPOUNDS HAVING TNAP INHIBITORY ACTIVITY
-
Page/Page column 153; 154; 155, (2018/07/29)
The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I) or a pharmacologically acceptable salt thereof.
Aza-β3-cyclopeptides: A new way of controlling nitrogen chirality
Mocquet, Clemence,Salauen, Arnaud,Claudon, Paul,Le Grel, Barbara,Potel, Michel,Guichard, Gilles,Jamart-Gregoire, Brigitte,Le Grel, Philippe
supporting information; experimental part, p. 14521 - 14525 (2010/02/28)
Sixteen and 24 membered aza-β3-peptidic macrocycles containing a α-hydrazinoacid or a β3-aminoacid were synthesized. The conformation of these pseudopeptides was determined by using NH chemical shift analysis, NH extinction, VT-NMR e